baber/WOPTO huggingface dataset:
Patent CA-3077653-A1 (CA)
Inventor: LAM WAI-SHAN
IPC: G06F3/16
Filed: 2018-10-11
Abstract: A system of crosstalk cancelled zone creation in audio playback comprising: main transducers emitting stereo soundwaves of an audio playback; a local system comprising at least two or more close-proximity-transducers (CPTs, each is arranged proximal to one of left and right-side ear canals of a listener. Each of the CPTs comprises: a position tracking device for tracking the relative positions of the main transducers to the CPT and the other CPTs; a control unit for receiving the relative position data from the position tracking device and generating control signal according to the relative position data for the generation of cross-talk cancellation (XTC) soundwaves. Each of the CPTs is configured to generate XTC soundwaves corresponding to the stereo soundwaves arriving at the corresponding ear of the listener. The generated XTC soundwaves are synchronized with the audio playback and with respect to the relative positions.
Patent CA-3080438-A1 (CA)
Title: Glazing assemblies with integrated photovoltaic structure and spacer structures for such glazing assemblies
Inventor: ANDERS SAMMY CHARLEY DAVE
IPC: E06B3/67
Filed: 2018-10-29
Abstract: Glazing assembly are described comprising at least a first (inner) glass pane, a second (outer) glass pane and at least one peripheral spacer structure for providing a predetermined separation between the first and second glass pane, the peripheral spacer structure being positioned at the peripheral area of the first and second glass pane; one or more photovoltaic (PV) cell modules mounted on at least part of the peripheral spacer structure, the one or more PV cell modules being positioned in the space defined by the first and second glass panes and the peripheral spacer structure (inter-pane space); wherein at least part of the peripheral spacer structure comprises one or more mounting members adapted to orient a light receiving surface of PV cells of the PV cell modules in a tilted position with respect to the plane of the second (outer) glass pane.
Patent CA-3084629-A1 (CA)
Inventor: RESES JACQUELINE
IPC: G06Q20/00
Filed: 2020-06-23
Abstract: La présente divulgation concerne, en partie, des techniques de génération de modèles prédictifs daprès des données de transaction passées et/ou des données dévénements futurs pour prédire : (i) quand un compte dun utilisateur ou dune utilisatrice devrait tomber sous une balance minimum associée à cet utilisateur ou cette utilisatrice, et/ou (ii) quand un compte a des fonds excédentaires qui peuvent être transféré, de manière sécuritaire, à un compte à rendement plus élevé pendant une certaine durée. En réponse à la détermination dune durée prédite pendant laquelle un compte devrait tomber sous la balance minimum, les techniques peuvent générer une offre pour prolonger le capital à un utilisateur ou une utilisatrice avant la durée prédite. En réponse à la détermination quun utilisateur, ou quune utilisatrice, a, ou aura, des fonds excédentaires, les techniques peuvent générer une offre pour déplacer une partie, ou la totalité, de ces fonds excédentaires dans un compte distinct fournissant un rendement plus élevé que celui du compte primaire de lutilisateur ou de lutilisatrice.
Patent CA-3087003-A1 (CA)
Inventor: FAVERO CEDRICK
IPC: C09K8/64
Filed: 2020-07-16
Abstract: The invention relates to a composition for preparing injection fluid in oil and gas recovery comprising an inverse emulsion of a water-soluble polymer A comprising acrylamide monomer units, and solid particles of a water-soluble polymer, wherein water-soluble polymer B is obtained by a polymerization step of at least acrylamide and 1 and 15 mol% of acrylamido tertiary butyl sulfonic acid (ATBS), and/or salts thereof, and a subsequent post treatment step of the resulting polymer. The invention also relates to a method of treating a portion of subterranean formation comprising providing the composition, preparing an injection fluid with at least the composition, introducing the injection fluid into portion of the subterranean formation. The composition is particularly useful to prepare fracturing fluid in fracturing operations.
Patent CA-3087627-A1 (CA)
Inventor: LEE SEOK MYUNG
IPC: C12N15/70
Filed: 2019-07-25
Abstract: La présente invention concerne un mutant de la protéine du récepteur CAMP, un micro-organisme le comprenant, et un procédé de production d'un acide L-aminé l'utilisant.
Patent CA-3090147-A1 (CA)
Inventor: FLICK EDWARD L
IPC: A63B71/00
Filed: 2019-02-04
Abstract: An adjustable weight kettlebell includes a body defining an internal cavity configured to receive one or more of a plurality of weights, and a weight selector assembly configured to selectively couple one or more of the plurality of weights to the body. The weight selector assembly may include an actuator to enable a user to select one of a plurality of available weight settings. The weight selector assembly may be locked for adjustment when the kettlebell is removed from a support surface such as a base, thereby inhibiting inadvertent detachment of the weights from the kettlebell during exercise. The weight selector assembly may automatically shift to the closest weight settings upon release of the actuator and may automatically unlock upon placement of the kettlebell on the support surface such as the base, the bottom weight if not coupled to the kettlebell, or any other suitable support surface.
Patent CA-3091224-A1 (CA)
Title: Use of cd33car modified high affinity nk cells (t-hank) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on nk cell activity)
Inventor: SOON-SHIONG PATRICK
IPC: C07K16/28
Filed: 2019-03-11
Abstract: The present application is directed to methods and compositions that are useful for reducing the number of myeloid-derived suppressor cells (MDSC), tumor associated macrophages (TAM), or both in a subject. The methods include administering an antigen binding protein that binds to an antigen expressed by MDSC and/or TAM, or administering a modified T cell or NK-92 cell that expresses an antigen binding protein that binds to an antigen expressed by MDSC and/or TAM, or a combination of both, to a subject. For example, the antigen binding protein can bind to CD33 expressed by MDSC and/or TAM. The methods and compositions are useful for treating a disease associated with MDSC and/or TAM infiltration into a tissue or tumor.
Patent CA-3091949-A1 (CA)
Title: Revetement de biocompatibilite pour la mesure continue d'analytes
Inventor: ZOU PENG
IPC: G01N33/543
Filed: 2019-02-26
Abstract: La présente invention concerne un biocapteur pour déterminer un analyte comprenant un module de capteur recouvert au moins partiellement par une couche de biocompatibilité, ladite couche de biocompatibilité comprenant un polymère possédant des groupes latéraux -CO-NR1R2, R1 et R2 étant choisis indépendamment parmi -H et C1-C6-alkyle. La présente invention concerne en outre un procédé de production dudit biocapteur, ainsi que des utilisations et des procédés d'utilisation associés audit biocapteur.
Patent CA-3094160-A1 (CA)
Inventor: INADA HIDEAKI
IPC: C12N15/00
Filed: 2019-03-29
Abstract: La présente invention concerne un procédé de production d'une molécule d'ARN simple brin en épingle à cheveux qui inhibe l'expression d'un gène cible. Le procédé comprend (i) une étape d'hybridation consistant à hybrider une première molécule d'oligoARN simple brin avec une deuxième molécule d'oligoARN simple brin et (ii) une étape de ligature consistant à ligaturer, à l'aide d'une ligase dans la famille des Rnl2, l'extrémité 3' de la première molécule d'oligoARN simple brin avec l'extrémité 5' de la deuxième molécule d'oligoARN simple brin. La séquence produite par la ligature de la première molécule d'oligoARN simple brin avec la deuxième molécule d'oligoARN simple brin contient une séquence d'inhibition d'expression génique dirigée sur le gène cible.
Patent CA-3094872-A1 (CA)
Title: Composition useful in metal sulfide scale removal
Inventor: PURDY CLAY
IPC: C02F5/00
Filed: 2020-10-01
Abstract: The present invention discloses a method and a composition for removing metal sulfide scale present on the surface of a metal, said method comprising: -    providing a liquid composition comprising: o    a chelating agent and a counterion component selected from the group consisting of: sodium gluconate; gluconic acid; tetrasodium EDTA; EDTA;  propylenediaminetetraacetic acid (PDTA); nitrilotriacetic acid (NTA); N-(2-hydroxyethyl)ethylenediaminetriacetic             acid                (HEDTA); diethylenetriaminepentaacetic acid (DTPA); hydroxyethyliminodiacetic acid (HEIDA); cyclohexylenediaminetetraacetic acid (CDTA); diphenylaminesulfonic acid (DPAS); ethylenediaminedi(o-hydroxyphenylacetic) acid (EDDHA);  glucoheptonic acid; gluconic acid; oxalic acid; malonic acid; succinic acid;  glutaric acid; adipic acid; pimelic acid; suberic acid; azelaic acid; sebacic acid;  phthalic acid;  terephthalic acid; aconitic acid; carballylic acid; trimesic acid; isocitric acid; citric acid; L-glutamic acid-N,N-diacetic acid (GLDA); salts thereof; and mixtures thereof.; and o    an aldehyde; and o    water -    exposing a surface contaminated with said metal sulfide scale to the liquid composition; -    allowing sufficient time of exposure to remove said metal sulfide scale from the contaminated surface and sequestration of the sulfur ions from solution.
Patent CA-3096503-A1 (CA)
Title: Connecting element for connecting profile elements
Inventor: FLUHRER DIETER
IPC: F16B2/18
Filed: 2019-04-15
Abstract: The invention relates to a connecting element (1) for connecting at least two profile elements (100, 200), wherein the connecting element (10) is rotatable about an axis of rotation (D to produce a clamping force, wherein the connecting element (10) has at least one first connecting section (12) and at least one second connecting section (14), which are each designed to be received in one of the profile elements (100, 200), wherein the first connecting section (12) has at least one first clamping face (20, 22), wherein the at least one first clamping face (20, 22) is designed with a predetermined clamping contour (KK1), wherein the second connecting section (14) has at least one second clamping face (24, 74), wherein the first clamping face (20, 22) faces the second connecting section (14) and the second clamping face (24, 74) faces the first connecting section (12), wherein the first connecting section (12) and the second connecting section (14) are formed in such a way that the profile elements (100, 200) connected via the connecting element (10) extend obliquely relative to each other or crosswise.
Patent CA-3097949-A1 (CA)
Title: Hpk1 inhibitors, preparation method and application thereof
Inventor: LIAO XUEBIN
IPC: C07D417/04
Filed: 2019-04-19
Abstract: Disclosed are HPK-1 inhibitors having a structure represented by Formula (X), pharmaceutical compositions comprising the HPK-1 inhibitors, methods of using the HPK-1 inhibitors, such as treating cancers, methods of preparing the HPK-1 inhibitors, and the synthetic intermediates.
Patent CA-3099531-A1 (CA)
Title: Catheter urinaire intelligent
Inventor: PALMER TIMOTHY A
IPC: A61M25/00
Filed: 2020-11-17
Abstract: CATHÉTER URINAIRE INTELLIGENT ABRÉGÉ DE LA DIVULGATION Il sagit dun cathéter urinaire auquel un capteur ou indicateur est fixé dans un endroit qui sera situé dans lécoulement de lurine lorsquun cathéter est utilisé. Lindicateur comprend un matériau de méchage électrolytique ayant une anode et une cathode sur le dessus et séparé à travers lespace. Le matériau de méchage pourrait être du papier. Lindicateur comprend également un transducteur de sortie positionné et raccordé par rapport à lanode et à la cathode de sorte quun circuit qui active le transducteur de sortie est créé lorsque lurine écoule. Lindicateur est configuré pour générer un signal de sortie reçu à un emplacement distant de sorte quun praticien médical puisse surveiller lutilisation appropriée du cathéter. Date Reçue/Date Received 2020-11-17
Patent CA-3099546-A1 (CA)
Inventor: SHORT GREGG R
IPC: B09B3/00
Filed: 2019-03-28
Abstract: Methods of disposing of pharmaceuticals including liquid pharmaceuticals and dissolved solid pharmaceuticals are disclosed. Pharmaceutical disposal kits are also disclosed.
Patent CA-3099619-A1 (CA)
Title: Composition comprenant de l'azote et une levure enrichie en selenium et procede pour augmenter la teneur en selenium dans des plantes par application de la composition sur des sols
Inventor: COR OLIVIER
IPC: A01N63/32
Filed: 2019-05-15
Abstract: La présente invention concerne un nouveau procédé d'augmentation de la teneur en sélénium de plantes par une application au sol d'une levure enrichie en sélénium et d'au moins une source d'azote.
Patent CA-3101052-A1 (CA)
Inventor: MERKLER DORON
IPC: A61K38/18
Filed: 2019-05-24
Abstract: La présente invention concerne des méthodes d'inhibition de l'inflammation cérébrale, comprenant l'administration d'un inhibiteur de CCR5 à un sujet.
Patent CA-3101738-A1 (CA)
Title: Composes pour le traitement de la douleur, compositions les comprenant, et leurs procedes d'utilisation
Inventor: DAX SCOTT L
IPC: C07D417/12
Filed: 2019-05-20
Abstract: L'invention concerne des composés de formule (I), des compositions les contenant, et des procédés de traitement et/ou de diminution de la douleur chez un sujet en ayant besoin. Les composés de formule (I) sont efficaces pour traiter la tachyphylaxie induite par les opioïdes et l'hyperalgie induite par les opioïdes.
Patent CA-3102231-A1 (CA)
Inventor: ROSSIGNOLI FILIPPO
IPC: C12N5/0775
Filed: 2019-05-31
Abstract: The method to produce conditionally apoptotic cells comprises modifying a cell population with a phenotype attributable to human adipose tissue-derived pericytes (AD-PC) expressing anti-tumor TRAIL introducing a sequence coding a conditional suicide gene (CSG).
Patent CA-3102422-A1 (CA)
Title: Framework with in-built anti-pollen/mosquito net
Inventor: MACHADO RAINHA HUGO MIGUEL
IPC: E05B63/06
Filed: 2018-06-07
Abstract: The present invention relates to an aluminium frame for producing doors or windows, which is applied to a door or window opening in a building. Said frame consists of at least one fixed rim (1) and fixed or movable panels (4) which comprise a central upright (6) and a reinforcing upright (5), handles (3) (7), and a roller of a mosquito/anti-pollen net (9), which is built into a profile (10). The frame comprises a system (2) for blocking the panels (4), which is built into the aluminium profiles of the fixed rim (1), as well as a system (8) for blocking the mosquito/anti-pollen net (9), which allows the profile (11) of the net (9) to be attached to the handle (7). The movements of the net (9) and the panels (4) can be manual or automatic and in both cases this movement is facilitated by a slide strip (13) with built-in ball bearings.
Patent CA-3103109-A1 (CA)
Title: Systemes de voies de guidage suspendues pour manutention automatique de materiaux
Inventor: BENEDICT CHARLES E
IPC: B65G63/00
Filed: 2015-08-24
Abstract: ABRÉGÉ DE LA DIVULGATION : Un chariot de support pour soutenir une unité de transfert dans un système de canal guidé suspendu pour la manutention automatisée comprend : quatre plaques cornières supérieures espacées et quatre poteaux, chacune des quatre plaques étant montée sur lun des quatre poteaux; une base soutenant les quatre poteaux et plaques cornières montées, chaque poteau étant soutenu sur un coin distinct de la base, la base comprenant également une ouverture centrale pour le passage dune broche raccordable à lunité de transfert; les quatre plaques cornières définissant un premier et un deuxième canal découvert, le premier canal étant recoupé par le deuxième canal pour permettre le passage du chariot de support aux environs dun socle de manière X-Y; et un ensemble de roulettes en bille sphériques et un ensemble de roulettes bidirectionnelles montées sur une surface inférieure de chacune des quatre plaques cornières supérieures espacées. Date reçue/Date Received 2020-12-18
Patent CA-3103704-A1 (CA)
Inventor: COMPTE ELSA
IPC: A61K49/00
Filed: 2019-07-05
Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
Patent CA-3105680-A1 (CA)
Title: Traitement des symptomes prurigineux de la maladie du foie
Inventor: SCIASCIA THOMAS
IPC: A61P17/04
Filed: 2019-07-10
Abstract: La présente invention concerne des méthodes de traitement de patients atteints de prurit associés à une maladie du foie au moyen de compositions antiprurigineuses; des procédés pour traiter des patients ayant un prurit associé à une cholestase obstructive faisant suite à une obstruction du canal biliaire due à une maladie de tissus non hépatiques; et les compositions anti-prurigineuses utilisées dans de tels procédés.
Patent CA-3107059-A1 (CA)
Inventor: MARIN GILDAS
IPC: G02C7/02
Filed: 2019-07-19
Abstract: The invention relates to a method for determining a value of a global sensitivity parameter (Sgsph, Sgcyl, Sgaxis, Sgasr, Sg J0, SgJ45, Soverall) of a subject, said global sensitivity parameter being relative to the sensitivity of said subject to a variation of at least a dioptric optical feature of at least an ophthalmic lens placed in front of at least one eye of said subject, comprising the following steps: a) determining (100) a single value of at least a first sensitivity parameter of said subject, relative to the sensitivity of the subject to a variation of a first dioptric optical feature of at least a first ophthalmic lens, b) determining (110) a single value of at least a second sensitivity parameter of said subject, relative to the sensitivity of the subject to a variation of a second dioptric optical feature of at least a second ophthalmic lens, each of the first and second sensitivity parameters being respectively related to the smallest variation of said first and second dioptric optical feature that may be perceived by the subject, c) using computing means to determine (120) said value of the global sensitivity parameter taking into account a combination of said single values of the first and second sensitivity parameters. It also related to methods using this value and a system for performing this method.
Patent CA-3108584-A1 (CA)
Inventor: SERVIES NICHOLAS
IPC: A47B77/00
Filed: 2021-02-11
Abstract: A cabinet assembly and cabinet assembly kit include two side panels and a rear panel coupled by hinge assemblies. Each hinge assembly includes a first bracket, a second bracket, and a linkage.  The first and second brackets each include a key that alternate to create a key channel when the one of the side panels is positioned at a generally right angle relative to the rear panel. Each hinge assembly permits the cabinet assembly to be configured in a folded configuration in which the side panels are parallel with the rear panel. A locking bracket includes a locking member sized and shaped to be inserted into the key channel. The locking bracket locks the side panel into a substantially right angle relative to the rear panel when the locking member is inserted into the key channel.
Patent CA-3108788-A1 (CA)
Title: Beverage capsule, associated filling method, capsule filling apparatus and beverage
Inventor: TITZ PETER
IPC: A47J31/06
Filed: 2021-02-09
Abstract: Disclosed is a capsule for the preparation of a beverage in a beverage machine by feeding liquid into the capsule and extracting a beverage out of the capsule.  The capsule comprises containment walls forming an interior cavity containing a beverage precursor for mixing with the liquid in the cavity, wherein the beverage precursor comprises a layer of compressed coffee precursor and a layer comprising a further substance, wherein the layer of compressed coffee precursor is more compressed than the layer comprising the further substance. Also disclosed is a capsule for the preparation of a beverage in a beverage machine by feeding liquid into the capsule and extracting a beverage out of the capsule through an outlet side of the capsule, wherein the capsule comprises containment walls forming an interior cavity containing a beverage precursor for mixing with the liquid in the cavity, wherein the beverage precursor comprises a layer of coffee precursor and a layer comprising a further substance comprising an algae product, wherein the layer comprising the further substance is located between the layer of coffee precursor and the outlet side. Also disclosed is a corresponding method of filling a capsule, a beverage obtained from a capsule and a capsule filling apparatus.
Patent CA-3109936-A1 (CA)
Inventor: CAI ZHIJUN
IPC: G05B15/02
Filed: 2019-09-04
Abstract: An engine controller to control a plurality of engines is disclosed. The engine controller may identify a plurality of engines configured to provide power to a load, wherein the plurality of engines have a first set of priorities associated with providing the power to the load; receive a plurality of parameters from a plurality of monitoring devices monitoring the plurality of engines; calculate a plurality of metrics corresponding to the plurality of engines based on the plurality of parameters; determine, based on the plurality of metrics, that a switching condition is satisfied to switch from the first set of priorities to a second set of priorities for the plurality of engines; determine the second set of priorities for the plurality of engines based on the plurality of metrics; and cause the plurality of engines to provide respective amounts of power to the load based on the second set of priorities.
Patent CA-3109954-A1 (CA)
Inventor: FAUSTMAN DENISE L
IPC: A61K39/395
Filed: 2019-08-20
Abstract: Described are antagonistic TNFR2 polypeptides, such as antibodies and antigen-binding fragments thereof, and the use of these polypeptides to inhibit the proliferation of regulatory T cells (T- regs) and/or myeloid-derived suppressor cells (MDSCs), to expand T effector cell populations or function, and to reduce the proliferation of, or directly kill, tumor cells, such as tumor cells that express TNFR2 antigen. The polypeptides, such as antibodies and antigen-binding fragments thereof, are TNFR2 antagonists, such as dominant TNFR2 antagonists. The polypeptides can be used to suppress the T-reg- or MDSC-mediated deactivation of tumor reactive T lymphocytes, expand populations of tumor-reactive cytotoxic T cells, and/or to directly kill TNFR2+ tumor cells. The antagonistic TNFR2 polypeptides described herein can be used to treat a wide variety of cancers and infectious diseases.
Patent CA-3111197-A1 (CA)
Title: Conveyor lifting device
Inventor: WOOD TRAVERS
IPC: B65G39/12
Filed: 2019-08-30
Abstract: A device for separating a conveying member from a support structure includes an elongated member for engaging a portion of the conveying member, and a lever. The elongated member includes a first end and a second end. The lever is coupled to at least one end of the elongated member, and the lever includes a base end and a distal end. The lever is pivotable between a first position in which the elongated member is lowered and a second position in which the elongated member is elevated.